| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Cardiovascular Diseases Unit, Clinical Pathology Laboratory (E.G.), Molecular Pathology Laboratory (N.P.), and Department of Medicina Sperimentale e Clinica G. Salvatore, University of Catanzaro, Magna Graecia, 88100 Catanzaro, Italy
Address all correspondence and requests for reprints to: Francesco Perticone, M.D., Dipartimento di Medicina Sperimentale e Clinica G. Salvatore, Policlinico Mater Domini, Via Tommaso Campanella, 88100 Catanzaro, Italy. E-mail: perticone{at}unicz.it
The association between angiotensin-converting enzyme (ACE) gene polymorphism and insulin resistance (IR) in hypertensive subjects remains controversial. Thus, we evaluated the possible association between IR and ACE gene polymorphism in a group of hypertensive, never-treated patients compared with that in a normotensive control group. We enrolled 200 (114 men and 86 women; age, 45.5 ± 4.7 yr) hypertensive patients and 96 (54 men and 42 women; age, 44.0 ± 4.7 yr) normotensive subjects. A double PCR assay was used to identify ACE genotypes. We determined fasting glucose and insulin by the glucose oxidase method and using a standard RIA technique. IR was estimated using the homeostasis model assessment (HOMAIR). Both fasting glucose (5.0 ± 0.3 vs. 4.7 ± 0.3 mmol/L; P < 0.0001), insulin levels (12.3 ± 4.7 vs. 4.9 ± 1.5 µU/mL; P < 0.0001), and HOMAIR (2.7 ± 1.1 vs. 1.1 ± 0.3; P < 0.0001) were significantly higher in hypertensive patients than in the normotensive control group. When we subdivided hypertensive patients according to ACE genotype, we observed that fasting insulin and HOMAIR were 16.3 ± 3.3 and 3.6 ± 0.8 in the DD genotype, 9.4 ± 3.1 and 2.1 ± 0.7 in the ID genotype, and 8.3 ± 2.8 and 1.9 ± 0.7 µU/mL in the II group (P < 0.0001, by ANOVA). No significant differences were observed in the normotensive control group. In conclusion, we extended previous data regarding the relationship of hypertension and IR by demonstrating a dependence of this relationship upon the ACE gene polymorphism.
This article has been cited by other articles:
![]() |
M. Nakhjavani, F. Esfahanian, A. Jahanshahi, A. Esteghamati, A. R. Nikzamir, A. Rashidi, and M. Zahraei The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2549 - 2553. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Han, X. Wang, Y. Cui, H. Ye, X. Tong, and M. Piao Relationship Between Angiotensin-Converting Enzyme Gene Insertion or Deletion Polymorphism and Insulin Sensitivity in Healthy Newborns Pediatrics, June 1, 2007; 119(6): 1089 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Dengel, M. D. Brown, R. E. Ferrell, T. H. Reynolds IV, and M. A. Supiano Exercise-induced changes in insulin action are associated with ACE gene polymorphisms in older adults Physiol Genomics, October 29, 2002; 11(2): 73 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Cosmo, G. Miscio, L. Zucaro, M. Margaglione, A. Argiolas, S. Thomas, G. Piras, R. Trevisan, P. C. Perin, S. Bacci, et al. The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1402 - 1407. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |